, Volume 10, Issue 1, pp 79–155

Osteoarthritis IV: Clinical therapeutic trials and treatment

  • W. W. Buchanan
  • W. F. Kean

DOI: 10.1163/156856002320752017

Cite this article as:
Buchanan, W.W. & Kean, W.F. Inflammopharmacology (2002) 10: 79. doi:10.1163/156856002320752017


This article discusses the potential usefulness of clinical therapeutic trials and criticises the failure of the value of guidelines in the management of osteoarthritis (OA). We have provided an overview of the benefits and side effects of non steroidal anti-inflammatory drugs (NSAIDs) in OA, including the introduction of the COX-2 selective inhibitors. In addition we have briefly reviewed the use of local NSAIDs, narcotic analgesics, injection methods, disease modifying drugs, gene therapy, surgical treatment, and non pharmacological intervention.

Copyright information

© VSP 2002 2002

Authors and Affiliations

  • W. W. Buchanan
  • W. F. Kean

There are no affiliations available